Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality
and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no …

Muscle wasting is a consequence of physiological changes or a pathology characterized by
increased catabolic activity that leads to progressive loss of skeletal muscle mass and …

Many patients with cancer experience poor nutritional status, which detrimentally impacts
clinical outcomes. Poor nutritional status in cancer is primarily manifested by severe muscle …

Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

Cancer cachexia (CC) is a multifactorial syndrome in patients with advanced cancer
characterized by weight loss via skeletal-muscle and adipose-tissue atrophy, catabolic …

Advanced cancer patients exhibit cachexia, a condition characterized by a significant
reduction in the body weight predominantly from loss of skeletal muscle and adipose tissue …

Long-chain noncoding RNAs (lncRNAs) are RNAs that do not code for proteins, widely
present in eukaryotes. They regulate gene expression at multiple levels through different …

Cachexia is a metabolic mutiny that directly reduces life expectancy in chronic conditions
such as cancer. The underlying mechanisms associated with cachexia involve inflammation …

It is well established that breast cancer development and progression depend not only on
tumor-cell intrinsic factors but also on its microenvironment and on the host characteristics …

Cancer cachexia is a multi-organ syndrome with unintentional weight loss, sarcopenia, and
systemic inflammation. Gastrointestinal (GI) cancer patients are more susceptible to …